GLP-1: Acute Effects on Kidney Function in Healthy Men
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01333163 |
Recruitment Status :
Completed
First Posted : April 11, 2011
Last Update Posted : December 15, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Kidney Functional | Biological: Human GLP-1 (7-36) amide Biological: Isotone NaCl | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 12 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Basic Science |
Official Title: | GLP-1: Acute Effects on Kidney Function in Healthy Men |
Study Start Date : | May 2011 |
Actual Primary Completion Date : | December 2011 |
Actual Study Completion Date : | December 2011 |
Arm | Intervention/treatment |
---|---|
Active Comparator: GLP-1 |
Biological: Human GLP-1 (7-36) amide
2 hour IV infusion, 1,5pmol/min/kg. |
Placebo Comparator: Placebo |
Biological: Isotone NaCl
2 hours IV infusion. |
- Glomerular Filtration Rate [ Time Frame: Every 20 minutes for 6 hours ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 30 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy young men
Exclusion Criteria:
- Any chronic diseases

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01333163
Denmark | |
Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG | |
Aarhus C, Denmark, 8000 |
Principal Investigator: | Jeppe Skov, MD | University of Aarhus |
Responsible Party: | Jeppe Skov, MD, University of Aarhus |
ClinicalTrials.gov Identifier: | NCT01333163 |
Other Study ID Numbers: |
VEKRM 29414 |
First Posted: | April 11, 2011 Key Record Dates |
Last Update Posted: | December 15, 2011 |
Last Verified: | December 2011 |